- Home
- HKPD vs ENLV Comparison
HKPD vs ENLV Comparison
Compare HKPD & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- ENLV
- Stock Information
- Founded
- HKPD 2016
- ENLV 2005
- Country
- HKPD Hong Kong
- ENLV Israel
- Employees
- HKPD N/A
- ENLV N/A
- Industry
- HKPD Other Pharmaceuticals
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- HKPD Health Care
- ENLV Health Care
- Exchange
- HKPD Nasdaq
- ENLV Nasdaq
- Market Cap
- HKPD 20.9M
- ENLV 23.7M
- IPO Year
- HKPD 2025
- ENLV 1995
- Fundamental
- Price
- HKPD $1.28
- ENLV $1.13
- Analyst Decision
- HKPD
- ENLV Strong Buy
- Analyst Count
- HKPD 0
- ENLV 2
- Target Price
- HKPD N/A
- ENLV $10.00
- AVG Volume (30 Days)
- HKPD 857.7K
- ENLV 101.3K
- Earning Date
- HKPD 01-01-0001
- ENLV 08-29-2025
- Dividend Yield
- HKPD N/A
- ENLV N/A
- EPS Growth
- HKPD N/A
- ENLV N/A
- EPS
- HKPD 0.21
- ENLV N/A
- Revenue
- HKPD $20,770,344.00
- ENLV N/A
- Revenue This Year
- HKPD N/A
- ENLV N/A
- Revenue Next Year
- HKPD N/A
- ENLV N/A
- P/E Ratio
- HKPD $6.09
- ENLV N/A
- Revenue Growth
- HKPD 32.91
- ENLV N/A
- 52 Week Low
- HKPD $0.81
- ENLV $0.81
- 52 Week High
- HKPD $3.79
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- HKPD N/A
- ENLV 62.52
- Support Level
- HKPD N/A
- ENLV $0.90
- Resistance Level
- HKPD N/A
- ENLV $1.30
- Average True Range (ATR)
- HKPD 0.00
- ENLV 0.09
- MACD
- HKPD 0.00
- ENLV 0.01
- Stochastic Oscillator
- HKPD 0.00
- ENLV 70.00
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.